companydata.dkcompanydata.dk

NOBEL BIOCARE DANMARK A/S: Financial statements 2017

CVR: 28293364

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 3,775,166 and a net result of DKK 580,387 compared with DKK 893,845 the year before. That is a decrease of 39.8% compared with the year before. Equity in the 2017 report amounted to DKK 4,435,300. The solvency ratio was 18.6%. The company had 4 employees in the financial year.

Gross Profit
DKK 3,775,166
Profit/Loss
DKK 580,387
Equity
DKK 4,435,300
Total Assets
DKK 23,857,474
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-3.8 mio.580 t.4.4 mio.4
2016-6.3 mio.894 t.3.9 mio.4
2015-5.5 mio.578 t.3 mio.-
2014-5.2 mio.430 t.2.4 mio.-
2013-5.3 mio.299 t.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on NOBEL BIOCARE DANMARK A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

NOBEL BIOCARE DANMARK A/S: The 2016 annual report is outJun 15, 2017

NOBEL BIOCARE DANMARK A/S has published its annual report for 2016. Gross profit came to DKK 6,274,224, and the net result was DKK 893,845.

Magnus K. Andreas Pettersson joins the board of NOBEL BIOCARE DANMARK A/SFeb 15, 2017

As of February 15, 2017, Magnus K. Andreas Pettersson has joined the board of directors of NOBEL BIOCARE DANMARK A/S.

Åsa Camilla Elisabeth Johnson leaves the board of NOBEL BIOCARE DANMARK A/SFeb 15, 2017

As of February 15, 2017, Åsa Camilla Elisabeth Johnson has left the board of directors of NOBEL BIOCARE DANMARK A/S.

About NOBEL BIOCARE DANMARK A/S

NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.

Source: annual report 2025, Danish Business Authority